Trans-arterial chemoperfusion for the treatment of liver metastases of breast cancer and colorectal cancer: Clinical results in palliative care patients

Table 2 Response Evaluation Criteria in Solid Tumors

Category	RECIST
CR	Disappearance of all tumour lesions
PR	Reduction of > 30% in total tumour size
SD	Reduction of < 30% or a growth of < 20%
PD	Growth of > 20% or occurrence of new lesions

RECIST: Response Evaluation Criteria in Solid Tumors; CR: Complete response; PR: Partial response; SD: Stable disease; PD: Progressive disease.